Company: STAA
Filing Date: 2025-10-30
Form Type: DEFA14A
Source: 0001193125-25-258558
Chunk: 22

Company: STAAR SURGICAL CO
Filing Date: 2025-10-30
Form: DEFA14A
Chunk 22
---
 second-largest active stockholder as of the September 12, 2025 record date for the Special Meeting, stating that Soleus is supportive of, and intends to vote in favor of, the Merger Proposal absent a material change in circumstance.

On October 2, 2025, the Broadwood Group published an investor presentation highlighting the rationale for its opposition to the Board’s recommendations on the Merger Proposal and the Compensation Proposal presented in this proxy statement.

On October 7, October 10 and October 15, 2025, each of Glass Lewis & Co. LLC, Egan-Jones Proxy Services and Institutional Shareholder Services, respectively, issued recommendations that STAAR’s stockholders vote AGAINST the Merger Proposal and AGAINST the Compensation Proposal.

On October 15, 2025, the Board met with members of STAAR’s management and representatives of Citi, Wachtell Lipton, Innisfree and Joele Frank Wilkinson Brimmer Katcher (“Joele Frank”) (the Company’s communications advisor) to discuss feedback and perspectives from stockholders and potential voting outcomes at the October 23, 2025 Special Meeting. Wachtell Lipton provided guidance to the Board regarding the Board’s fiduciary duties under Delaware law and certain of STAAR’s contractual obligations under the Merger Agreement.

Thereafter, during the period from October 15, 2025 through the date of this Supplement, members of Alcon’s and STAAR’s management and their respective advisors engaged in discussions regarding recent developments and potential next steps, including the possibility of adjourning or postponing the Special Meeting, resetting the record date for the Special Meeting and/or adopting a stockholder rights plan. Further, they discussed various approaches and considerations relative to amending the Merger Agreement, including the potential to provide for a price increase, to add a “go-shop”period so that STAAR could solicit alternative proposals from potential bidders, to eliminate the termination fee payable by STAAR in order to accept a superior offer arising during the go-shopperiod and Alcon’s related right to “match” any such superior offer, to add a termination right of STAAR, and other potential changes to the Merger Agreement. Over the course of such discussions, Alcon and STAAR discussed potential engagement with STAAR stockholders and proxy advisory firms to understand their perspectives on valuation and other aspects of the proposed Merger.

14

On October 20, 2025, STAAR announced preliminary net sales results for the third